Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma

Background/Aim: Despite early detection by widespread use of abdominal imaging more than 40% of patients with conventional renal cell carcinoma (RCC) will die due to metastatic disease. Small kinase inhibitors for AXL receptor tyrosine kinase may delay the progression of metastatic cRCC. Patients an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Peterfi, Lehel (VerfasserIn) , Bjercke, Thea (VerfasserIn) , Yusenko, Maria V. (VerfasserIn) , Kovacs, Gyula (VerfasserIn) , Banyai, Daniel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Jun 2020
In: Anticancer research
Year: 2020, Jahrgang: 40, Heft: 6, Pages: 3485-3489
ISSN:1791-7530
DOI:10.21873/anticanres.14335
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21873/anticanres.14335
Verlag, lizenzpflichtig, Volltext: http://ar.iiarjournals.org/content/40/6/3485
Volltext
Verfasserangaben:Lehel Peterfi, Thea Bjercke, Maria V. Yusenko, Gyula Kovacs, and Daniel Banyai

MARC

LEADER 00000caa a2200000 c 4500
001 172668363X
003 DE-627
005 20230427082114.0
007 cr uuu---uuuuu
008 200810s2020 xx |||||o 00| ||eng c
024 7 |a 10.21873/anticanres.14335  |2 doi 
035 |a (DE-627)172668363X 
035 |a (DE-599)KXP172668363X 
035 |a (OCoLC)1341354714 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Peterfi, Lehel  |e VerfasserIn  |0 (DE-588)1187980692  |0 (DE-627)1666944742  |4 aut 
245 1 0 |a Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma  |c Lehel Peterfi, Thea Bjercke, Maria V. Yusenko, Gyula Kovacs, and Daniel Banyai 
264 1 |c Jun 2020 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.08.2020 
520 |a Background/Aim: Despite early detection by widespread use of abdominal imaging more than 40% of patients with conventional renal cell carcinoma (RCC) will die due to metastatic disease. Small kinase inhibitors for AXL receptor tyrosine kinase may delay the progression of metastatic cRCC. Patients and Methods: We analysed AXL expression by immunohistochemistry on tissue multi arrays of 691 conventional RCC without metastasis at the time of nephrectomy. Results: The Kaplan-Meier survival analysis indicated a poor disease-specific survival rates for patients with tumour showing cytoplasmic AXL staining, whereas expression on the cell membrane is associated with excellent disease outcome. Multivariate Cox regression analysis identified cytoplasmic AXL expression as an independent prognostic factor indicating a five-times higher risk of postoperative tumour progression (RR=5.048; 95% CI=2.391-10.657; p<0.001). Conclusion: Detecting cytoplasmic expression of AXL can be used to define a subset of conventional RCC with high risk of progression, thus identifying patients for more aggressive surveillance and adjuvant AXL inhibitor treatment as early as possible. 
650 4 |a AXL expression 
650 4 |a Conventional RCC 
650 4 |a immunohistochemistry 
650 4 |a tumor progression 
700 1 |a Bjercke, Thea  |e VerfasserIn  |4 aut 
700 1 |a Yusenko, Maria V.  |e VerfasserIn  |4 aut 
700 1 |a Kovacs, Gyula  |e VerfasserIn  |0 (DE-588)1081747579  |0 (DE-627)846587424  |0 (DE-576)454756399  |4 aut 
700 1 |a Banyai, Daniel  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 40(2020), 6, Seite 3485-3489  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma 
773 1 8 |g volume:40  |g year:2020  |g number:6  |g pages:3485-3489  |g extent:5  |a Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma 
856 4 0 |u https://doi.org/10.21873/anticanres.14335  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://ar.iiarjournals.org/content/40/6/3485  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200810 
993 |a Article 
994 |a 2020 
998 |g 1081747579  |a Kovacs, Gyula  |m 1081747579:Kovacs, Gyula  |d 50000  |e 50000PK1081747579  |k 0/50000/  |p 4 
999 |a KXP-PPN172668363X  |e 3737249369 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2004","publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-","publisherPlace":"Kapandriti, Attiki, Greece"}],"id":{"eki":["387478493"],"zdb":["2145376-7"],"issn":["1791-7530"]},"name":{"displayForm":["International Institute of Anticancer Research"]},"pubHistory":["Nachgewiesen 24.2004 -"],"part":{"volume":"40","text":"40(2020), 6, Seite 3485-3489","extent":"5","year":"2020","issue":"6","pages":"3485-3489"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 26.02.13"],"disp":"Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinomaAnticancer research","recId":"387478493","language":["eng"],"title":[{"title_sort":"Anticancer research","subtitle":"international journal of cancer research and treatment","title":"Anticancer research"}]}],"physDesc":[{"extent":"5 S."}],"id":{"doi":["10.21873/anticanres.14335"],"eki":["172668363X"]},"origin":[{"dateIssuedDisp":"Jun 2020","dateIssuedKey":"2020"}],"name":{"displayForm":["Lehel Peterfi, Thea Bjercke, Maria V. Yusenko, Gyula Kovacs, and Daniel Banyai"]},"language":["eng"],"recId":"172668363X","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.08.2020"],"title":[{"title_sort":"Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma","title":"Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma"}],"person":[{"given":"Lehel","family":"Peterfi","role":"aut","display":"Peterfi, Lehel","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Bjercke, Thea","roleDisplay":"VerfasserIn","given":"Thea","family":"Bjercke"},{"family":"Yusenko","given":"Maria V.","display":"Yusenko, Maria V.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kovacs, Gyula","given":"Gyula","family":"Kovacs"},{"family":"Banyai","given":"Daniel","display":"Banyai, Daniel","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a PETERFILEHCYTOPLASMI2020